HHS endorses DEA move to schedule synthetic kratom extracts

• Federal authorities and lawmakers are cracking down on synthetic concentrates of kratom, an herbal product sold legally over the counter in most states, as concerns rise over their risk to public health.
• The Drug Enforcement Administration (DEA) signaled heightened concerns about kratom-derived extracts earlier this year when it announced plans to temporarily ban products containing concentration
• " In July, the DEA announced plans to temporarily schedule a psychoactive compound derived from kratom...